[Study of cellular immunity in patients with Mediterranean visceral leishmaniasis]. 1990

S Dunan, and C Meller, and S Kaplanski, and C Mary, and B Faugère, and J Franck, and I Toga, and C Farnarier, and M Quilici
Laboratoire de Parasitologie, Faculté de Médecine, Marseille, France.

Cellular immunity against Leishmania infantum antigens was studied in visceral leishmaniasis patients and healthy subjects living in a endemic area. Only the healthy subjects were TTL positive with production of gamma interferon, whereas the visceral leishmaniasis patients presented a transitory inhibition of their specific cellular response mechanisms.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007223 Infant A child between 1 and 23 months of age. Infants
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D007893 Leishmania donovani A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes visceral leishmaniasis (LEISHMANIASIS, VISCERAL). The sandfly genera Phlebotomus and Lutzomyia are the vectors. Leishmania (Leishmania) donovani,Leishmania leishmania donovani,Leishmania donovanus,Leishmania leishmania donovanus,donovani, Leishmania leishmania,donovanus, Leishmania,donovanus, Leishmania leishmania,leishmania donovanus, Leishmania
D007898 Leishmaniasis, Visceral A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. Black Fever,Kala-Azar,Fever, Black,Kala Azar,Visceral Leishmaniasis
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S Dunan, and C Meller, and S Kaplanski, and C Mary, and B Faugère, and J Franck, and I Toga, and C Farnarier, and M Quilici
November 2009, Journal of clinical microbiology,
S Dunan, and C Meller, and S Kaplanski, and C Mary, and B Faugère, and J Franck, and I Toga, and C Farnarier, and M Quilici
January 2011, Bulletin de l'Academie nationale de medecine,
S Dunan, and C Meller, and S Kaplanski, and C Mary, and B Faugère, and J Franck, and I Toga, and C Farnarier, and M Quilici
January 1999, Presse medicale (Paris, France : 1983),
S Dunan, and C Meller, and S Kaplanski, and C Mary, and B Faugère, and J Franck, and I Toga, and C Farnarier, and M Quilici
March 2003, Le infezioni in medicina,
S Dunan, and C Meller, and S Kaplanski, and C Mary, and B Faugère, and J Franck, and I Toga, and C Farnarier, and M Quilici
January 1994, Scandinavian journal of infectious diseases,
S Dunan, and C Meller, and S Kaplanski, and C Mary, and B Faugère, and J Franck, and I Toga, and C Farnarier, and M Quilici
April 1976, The Journal of tropical medicine and hygiene,
S Dunan, and C Meller, and S Kaplanski, and C Mary, and B Faugère, and J Franck, and I Toga, and C Farnarier, and M Quilici
January 1995, Bulletin of the World Health Organization,
S Dunan, and C Meller, and S Kaplanski, and C Mary, and B Faugère, and J Franck, and I Toga, and C Farnarier, and M Quilici
June 2009, Clinical and vaccine immunology : CVI,
S Dunan, and C Meller, and S Kaplanski, and C Mary, and B Faugère, and J Franck, and I Toga, and C Farnarier, and M Quilici
March 2018, European journal of rheumatology,
S Dunan, and C Meller, and S Kaplanski, and C Mary, and B Faugère, and J Franck, and I Toga, and C Farnarier, and M Quilici
January 2012, Journal of tropical medicine,
Copied contents to your clipboard!